Evidence map›Paper›PMID 39802850›Full record

ReviewEuroasian journal of hepato-gastroenterology

Newer Diagnostic Virological Markers for Hepatitis B Virus Infection.

Reshu Agarwal, Ekta Gupta, Jasmine Samal, Sheetalnath Rooge, Akshita Gupta

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Reshu AgarwalDepartment of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-9207-3607
Ekta GuptaDepartment of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.ORCID https://orcid.org/0000-0002-5237-216x
Jasmine SamalDepartment of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.
Sheetalnath RoogeDepartment of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.
Akshita GuptaDepartment of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic Hepatitis B (CHB) remains a major public health problem, leading to various complications such as liver fibrosis, cirrhosis, and hepatocellular carcinoma. The existing diagnostic markers for Hepatitis B virus (HBV) are limited in distinguishing different CHB phases and intra-hepatic viral replication activity. In the past few years, several non-invasive potential blood markers that reflect viral intra-hepatic replicative state more accurately have been in progress and are gaining importance. Despite substantial efforts, the clinical utility of these new markers in CHB management is limited and unexplored. Therefore, in this review, we will discuss some of the newer HBV markers, their potential role in the diagnosis and monitoring of CHB patients. How to cite this article: Agarwal R, Gupta E, Samal J,

Indexed as

Chronic Hepatitis Bcovalently closed circular DNAHepatitis B core-related antigenHepatitis B surface antigenHepatitis B virusHepatitis B virus DNAHepatitis B virus RNAIntegrated DNA

Identifiers

PMID39802850
PMCPMC11714116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.